News

Under the partnership, both the companies will combine their expertise in cellular reprogramming to address the challenges around deriving non-viral, non-integrating, clinically-relevant induced pluripotent stem (iPS) cells for

The LiverDig 100 assay panel, which is based on the MRM technology, is suitable for use in various pre-clinical applications including mode of action studies, screening and validation

According to the company, the new Reboost product line includes four cold, cough and flu products under a single brand. Heel CEO Cliff Clive was quoted by Drug

Under the new plans, the company will expand its existing capabilities to include formulation development and Good Manufacturing Processes (GMP) contract manufacturing services for solid dispersions and oral

CoCo Therapeutics will work to develop new treatments for Alzheimer’s disease, which is based on the research of Prof. Jonathan Corcoran. The company, which will be funded through

As per the new agreement, OET will gain the rights to use ProteoNic’s UNic translation enhancing elements in its flashBAC system for third party recombinant protein production services.

The monoclonal antibody, Vedolizumab, antagonizes alpha4beta7 (-4ß7) integrin expressed on a subset of circulating white blood cells and treat most common types of inflammatory bowel diseases (IBD) such

As per the agreement, Roche will provide R&D funding and scientific support to BioLamina. The financial terms and conditions of the deal were undisclosed. Roche’s Biochemical Reagents and

Since 2008, DKSH Healthcare is providing Market Expansion Services to Advance Pharma in West Malaysia. The extended partnership between DKSH and Advance Pharma in Malaysia aims to demonstrate